Delivery Order SPE2DB22D2103-SPE2DB25FR8TQ
Award Date
1/16/25
Potential Completion Date
2/7/25
Potential Value
$5.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $5,288.86 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply the antineoplastic agent Bosulif 500 mg tablets. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,523.71 firm fixed-price delivery order is for the supply of BOSULIF 100 MG TABLET 120S, a specialized pharmaceutical product. The contract has an ultimate completion date of December 27, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,334.07 firm fixed-price delivery order is for the supply of BOSULIF 400 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of March 25, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,955.43 firm fixed price contract is for the delivery of BOSULIF 400 MG TABLET 30S, a prescription medication, with a completion date of November 6, 2024. The contract is an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026. This IDC serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of BOSULIF 400 MG TABLET 30S, a specialty pharmaceutical product. The contract has a firm fixed price of $22,668.14 and a completion date of December 13, 2024. This is a delivery order contract, not associated with a larger contract vehicle. There is no set-aside designation mentioned, indicating this was an open...
This federal contract award, with a ceiling value of $10,955.43, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of BOSULIF 400 MG TABLET 30S, a prescription medication, to support the healthcare needs of government agencies and programs. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999, that...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical company Amerisourcebergen Corporation. The $4,991.27 firm fixed price delivery order is for the supply of 120 tablets of the prescription drug BOSULIF 100 MG. This award is not associated with any set-aside designations. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a large pharmaceutical distribution company. The $10,955.43 contract is for the supply of the prescription medication Bosulif (bosutinib) 400 mg tablets, with a period of performance through September 9, 2024. The award is not associated with a set-aside program. As a major supplier of medical commodities to federal agencies, AmerisourceBergen has been awarded numerous...
This federal contract award is for the delivery of BOSULIF 400 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a total ceiling value of $11,334.07 and was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the performance location is Conshohocken, PA. The contract does not have a set-aside designation, indicating open competition....
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract worth $157,682.91 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a firm fixed price and runs through November 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic...